Suven Life Sciences has informed that the details of securities dematerialized/ rematerialized during the quarter ended June 30, 2020, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished by KFin Technologies, Registrar & Transfer Agent of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies dated July 04, 2020 are enclosed for reference.
The above information is a part of company’s filings submitted to BSE.
